Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9351)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2014 (publication date) through Oct 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiang CM, Pu CW, Hou YH, Chen Z, Alanazy M, Hebbard L. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. World J Gastroenterol 2014; 20(44): 16464-16473 [PMID: 25469014 DOI: 10.3748/wjg.v20.i44.16464] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i44/16464.htm |
| Number | Citing Articles |
| 1 |
Min Yao, Wenjie Zheng, Li Wang, Miao Fang, Zhizhen Dong, Dengfu Yao. Neoplasm. 2018; doi: 10.5772/intechopen.77400
|
| 2 |
David W Russell, Markus Grompe. Adeno-associated virus finds its disease. Nature Genetics 2015; 47(10): 1104 doi: 10.1038/ng.3407
|
| 3 |
Keith Pereira, Jason Salsamendi, Javier Casillas. The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know. Journal of Clinical Imaging Science 2015; 5: 32 doi: 10.4103/2156-7514.157860
|
| 4 |
Qiyi Yu, Yidong Zhang, Jiaping Ni, Yumeng Shen, Weiwei Hu. Identification and analysis of significant genes in nonalcoholic steatohepatitis-hepatocellular carcinoma transformation: Bioinformatics analysis and machine learning approach. Molecular Immunology 2024; 174: 18 doi: 10.1016/j.molimm.2024.07.015
|
| 5 |
Yuji Ogawa, Masato Yoneda, Takashi Kobayashi, Yasushi Honda, Takaomi Kessoku, Kento Imajo, Satoru Saito, Atsushi Nakajima. Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults. Expert Opinion on Pharmacotherapy 2019; 20(1): 69 doi: 10.1080/14656566.2018.1543403
|
| 6 |
Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Vimal Pandey, Jomon Joseph, Rajashekar Mohan, Praveen Kumar Shetty, Manoj Kumar Bhat. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4. Scientific Reports 2016; 6(1) doi: 10.1038/srep27558
|
| 7 |
Cathrin Sellmann, Cheng Jun Jin, Anna Janina Engstler, Jean-Pascal De Bandt, Ina Bergheim. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD). European Journal of Nutrition 2017; 56(8): 2519 doi: 10.1007/s00394-016-1287-9
|
| 8 |
|
| 9 |
Wei Chang, Jingjing Wang, Yuanqi You, Hongqian Wang, Shendong Xu, Stephen Vulcano, Changlu Xu, Chenlin Shen, Zhi Li, Jie Wang. Triptolide Reduces Neoplastic Progression in Hepatocellular Carcinoma by Downregulating the Lipid Lipase Signaling Pathway. Cancers 2024; 16(3): 550 doi: 10.3390/cancers16030550
|
| 10 |
Mitsuyoshi Yamagata, Mutsumi Tsuchishima, Takashi Saito, Mikihiro Tsutsumi, Joseph George. Therapeutic implication of human placental extract to prevent liver cirrhosis in rats with metabolic dysfunction-associated steatohepatitis. Clinical Science 2024; 138(5): 327 doi: 10.1042/CS20230533
|
| 11 |
Teruhisa Higuchi, Mitsuhiko Moriyama, Akiko Fukushima, Hiroshi Matsumura, Shunichi Matsuoka, Tatsuo Kanda, Masahiko Sugitani, Akiko Tsunemi, Takahiro Ueno, Noboru Fukuda. Association of mRNA expression of iron metabolism-associated genes and progression of non-alcoholic steatohepatitis in rats. Oncotarget 2018; 9(40): 26183 doi: 10.18632/oncotarget.25488
|
| 12 |
Paola Dongiovanni, Marica Meroni, Salvatore Petta, Miriam Longo, Anna Alisi, Giorgio Soardo, Luca Valenti, Luca Miele, Stefania Grimaudo, Grazia Pennisi, Grieco Antonio, Dario Consonni, Silvia Fargion, Anna Ludovica Fracanzani. Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(10): 158765 doi: 10.1016/j.bbalip.2020.158765
|
| 13 |
Paola Berenice Mass Sanchez, Marinela Krizanac, Ralf Weiskirchen, Anastasia Asimakopoulos. Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights. International Journal of Molecular Sciences 2021; 22(10): 5284 doi: 10.3390/ijms22105284
|
| 14 |
Ana-Lucia Blendea, Ioan Gotcă , Teodora-ELena Huțanu , Alin Ciobîcă , Daniela Dumitriu . Exploring the interplay of Emotional intelligence and stress. Bulletin of Integrative Psychiatry 2024; 101(2): 45 doi: 10.36219/BPI.2024.2.05
|
| 15 |
Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. World Journal of Gastroenterology 2015; 21(22): 6820-6834 doi: 10.3748/wjg.v21.i22.6820
|
| 16 |
R Díaz-Rúa, E M van Schothorst, J Keijer, A Palou, P Oliver. Isocaloric high-fat feeding directs hepatic metabolism to handling of nutrient imbalance promoting liver fat deposition. International Journal of Obesity 2016; 40(8): 1250 doi: 10.1038/ijo.2016.47
|
| 17 |
Eman D. Mohammed, Ashraf B. Abdel-Naim, Jin Kangpeng, Runqiu Jiang, Jifu Wei, Beicheng Sun. The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer. Life Sciences 2021; 264: 118615 doi: 10.1016/j.lfs.2020.118615
|
| 18 |
Takashi Saito, Mutsumi Tsuchishima, Mikihiro Tsutsumi, Joseph George. Molecular pathogenesis of metabolic dysfunction‐associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis. Journal of Cellular and Molecular Medicine 2024; 28(12) doi: 10.1111/jcmm.18491
|
| 19 |
Seyed Moayed Alavian, Hosein Zadi. The Relation Between Non-alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease. Multidisciplinary Cardiovascular Annals 2022; 13(1) doi: 10.5812/mca-121262
|
| 20 |
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World Journal of Hepatology 2017; 9(11): 533-543 doi: 10.4254/wjh.v9.i11.533
|
| 21 |
Vasilios G Athyros. Statins for the Treatment of Non Alcoholic Fatty Liver Disease in Patients with Metabolic Syndrome. Journal of Diabetes, Metabolic Disorders & Control 2016; 3(1) doi: 10.15406/jdmdc.2016.03.00057
|
| 22 |
Katharina Luise Hupa-Breier, Janine Dywicki, Björn Hartleben, Freya Wellhöner, Benjamin Heidrich, Richard Taubert, Young-Seon Elisabeth Mederacke, Maren Lieber, Konstantinos Iordanidis, Michael P. Manns, Heiner Wedemeyer, Matthias Hardtke-Wolenski, Elmar Jaeckel. Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH. Biomedicines 2021; 9(4): 353 doi: 10.3390/biomedicines9040353
|
| 23 |
Xuebin Shen, Mengting Chen, Jian Zhang, Yifan Lin, Xinyue Gao, Jionghong Tu, Kunqi Chen, An Zhu, Shanghua Xu. Unveiling the Impact of ApoF Deficiency on Liver and Lipid Metabolism: Insights from Transcriptome-Wide m6A Methylome Analysis in Mice. Genes 2024; 15(3): 347 doi: 10.3390/genes15030347
|
| 24 |
Qinguo Li, Guoqian Tan, Fan Wu. The functions and roles of C2H2 zinc finger proteins in hepatocellular carcinoma. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1129889
|
| 25 |
Silvia Zappavigna, Daniela Vanacore, Stefania Lama, Nicoletta Potenza, Aniello Russo, Pasquale Ferranti, Marcello Dallio, Alessandro Federico, Carmelina Loguercio, Pasquale Sperlongano, Michele Caraglia, Paola Stiuso. Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells. International Journal of Molecular Sciences 2019; 20(9): 2190 doi: 10.3390/ijms20092190
|
| 26 |
Ben-Chen Rao, Jia-Min Lou, Wei-Jie Wang, Ang Li, Guang-Ying Cui, Zu-Jiang Yu, Zhi-Gang Ren. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2020; 19(2): 109 doi: 10.1016/j.hbpd.2020.01.003
|
| 27 |
Hao-ran Ding, Jing-lin Wang, Hao-zhen Ren, Xiao-lei Shi. Lipometabolism and Glycometabolism in Liver Diseases. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/1287127
|
| 28 |
Zhen-Ya Lu, Chao Cen, Zhou Shao, Xin-Hua Chen, Cheng-Fu Xu, You-Ming Li. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study. World Journal of Gastroenterology 2016; 22(5): 1884-1890 doi: 10.3748/wjg.v22.i5.1884
|
| 29 |
C. Miethe, H. Nix, R. Martin, A. R. Hernandez, R. S. Price. Silibinin Reduces the Impact of Obesity on Invasive Liver Cancer. Nutrition and Cancer 2017; 69(8): 1272 doi: 10.1080/01635581.2017.1367935
|
| 30 |
Pasquale Agosti, Carlo Sabbà, Antonio Mazzocca. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(2): 607 doi: 10.1016/j.bbadis.2017.11.026
|
| 31 |
Konstantinos Kargiotis, Vasilios G Athyros, Olga Giouleme, Niki Katsiki, Evangelia Katsiki, Panagiotis Anagnostis, Chrysoula Boutari, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome. World Journal of Gastroenterology 2015; 21(25): 7860-7868 doi: 10.3748/wjg.v21.i25.7860
|
| 32 |
Ali A. Mencin, Rohit Loomba, Joel E. Lavine. Caring for children with NAFLD and navigating their care into adulthood. Nature Reviews Gastroenterology & Hepatology 2015; 12(11): 617 doi: 10.1038/nrgastro.2015.146
|
| 33 |
Catherine T. Frenette, Ari J. Isaacson, Irene Bargellini, Sammy Saab, Amit G. Singal. A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2019; 3(3): 302 doi: 10.1016/j.mayocpiqo.2019.04.005
|
| 34 |
Zhuanchang Wu, Hongxin Ma, Liyuan Wang, Xiaojia Song, Jie Zhang, Wen Liu, Yutong Ge, Yang Sun, Xiangguo Yu, Zehua Wang, Jianping Wang, Yankun Zhang, Chunyang Li, Nailin Li, Lifen Gao, Xiaohong Liang, Xuetian Yue, Chunhong Ma. Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake. Cell Death & Differentiation 2020; 27(5): 1693 doi: 10.1038/s41418-019-0453-z
|
| 35 |
Adriana R. Schultz Moreira, Sabrina Rüschenbaum, Stefan Schefczyk, Ulrike Hendgen-Cotta, Tienush Rassaf, Ruth Broering, Matthias Hardtke-Wolenski, Laura Elisa Buitrago-Molina. 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes. International Journal of Molecular Sciences 2020; 21(21): 8279 doi: 10.3390/ijms21218279
|
| 36 |
Eman D. Mohammed, Zechuan Zhang, Wenfang Tian, Venkatanarayana Gangarapu, A.A. Al-Gendy, Jun Chen, Jifu Wei, Beicheng Sun. Modulation of IR as a therapeutic target to prevent NASH using NRF from Diceratella elliptica (DC.) jonsell. Strong Nrf2 and leptin inducer as well as NF-kB inhibitor. Phytomedicine 2021; 80: 153388 doi: 10.1016/j.phymed.2020.153388
|
| 37 |
Kelli A. Lytle, Christopher M. Depner, Carmen P. Wong, Donald B. Jump. Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr mice by targeting the TGFβ-Smad3 pathway. Journal of Lipid Research 2015; 56(10): 1936 doi: 10.1194/jlr.M061275
|
| 38 |
Meirav Pevsner-Fischer, Timur Tuganbaev, Mariska Meijer, Sheng-Hong Zhang, Zhi-Rong Zeng, Min-Hu Chen, Eran Elinav. Role of the microbiome in non-gastrointestinal cancers. World Journal of Clinical Oncology 2016; 7(2): 200-213 doi: 10.5306/wjco.v7.i2.200
|
| 39 |
Andra-Iulia Suceveanu, Laura Mazilu, Andreea-Daniela Gheorghe, Anca Pantea Stoian, Felix Voinea, Adrian-Paul Suceveanu. Liver Cancer. 2018; doi: 10.5772/intechopen.80527
|